Ampudia-Blasco FJ - Search Results

1

A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetes.

Ampudia-Blasco FJ, Benhamou PY, Charpentier G, Consoli A, Diamant M, Gallwitz B, Khunti K, Mathieu C, Ridderstråle M, Seufert J, Tack C, Vilsbøll T, Phan TM, Stoevelaar H. Ampudia-Blasco FJ, et al. Diabetes Technol Ther. 2015 Mar;17(3):194-202. doi: 10.1089/dia.2014.0260. Epub 2014 Oct 27. Diabetes Technol Ther. 2015. PMID: 25347226 Free PMC article.

2

[Importance of daily glycemic variability in achieving glycemic targets in type 2 diabetes: role of DPP-4 inhibitors].

Ampudia-Blasco FJ, Ceriello A. Ampudia-Blasco FJ, et al. Med Clin (Barc). 2010 Sep;135 Suppl 2:33-9. doi: 10.1016/S0025-7753(10)70031-2. Med Clin (Barc). 2010. PMID: 21420536 Review. Spanish.

3

Basal plus basal-bolus approach in type 2 diabetes.

Ampudia-Blasco FJ, Rossetti P, Ascaso JF. Ampudia-Blasco FJ, et al. Diabetes Technol Ther. 2011 Jun;13 Suppl 1:S75-83. doi: 10.1089/dia.2011.0001. Diabetes Technol Ther. 2011. PMID: 21668340 Review.

4

Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets.

DeVries JH, Bain SC, Rodbard HW, Seufert J, D'Alessio D, Thomsen AB, Zychma M, Rosenstock J; Liraglutide-Detemir Study Group. DeVries JH, et al. Diabetes Care. 2012 Jul;35(7):1446-54. doi: 10.2337/dc11-1928. Epub 2012 May 14. Diabetes Care. 2012. PMID: 22584132 Free PMC article. Clinical Trial.

5

Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.

Rossetti P, Ampudia-Blasco FJ, Laguna A, Revert A, Vehì J, Ascaso JF, Bondia J. Rossetti P, et al. Diabetes Technol Ther. 2012 Nov;14(11):1043-52. doi: 10.1089/dia.2012.0145. Epub 2012 Sep 24. Diabetes Technol Ther. 2012. PMID: 23003329 Free PMC article. Clinical Trial.

6

A cross-sectional survey among patients and prescribers on insulin dosing irregularities and impact of mild (self-treated) hypoglycemia episodes in Spanish patients with type 2 diabetes as compared to other European patients.

Ampudia-Blasco FJ, Galán M, Brod M. Ampudia-Blasco FJ, et al. Endocrinol Nutr. 2014 Oct;61(8):426-33. doi: 10.1016/j.endonu.2014.03.008. Epub 2014 May 20. Endocrinol Nutr. 2014. PMID: 24853553

7

Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitus.

Romera I, Ampudia-Blasco FJ, Pérez A, Ariño B, Pfarr E, Giljanovic Kis S, Naderali E. Romera I, et al. Endocrinol Nutr. 2016 Dec;63(10):519-526. doi: 10.1016/j.endonu.2016.06.003. Epub 2016 Aug 28. Endocrinol Nutr. 2016. PMID: 27578024 English, Spanish.

8

Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide (iGlarLixi) vs insulin glargine and lixisenatide monocomponents.

Davies MJ, Leiter LA, Guerci B, Grunberger G, Ampudia-Blasco FJ, Yu C, Stager W, Niemoeller E, Souhami E, Rosenstock J. Davies MJ, et al. Diabetes Obes Metab. 2017 Dec;19(12):1798-1804. doi: 10.1111/dom.12980. Epub 2017 Jul 7. Diabetes Obes Metab. 2017. PMID: 28432746 Free PMC article. Clinical Trial.

9

Validation in daily clinical situations of Diascope^®, a software developed to help healthcare professionals individualize antidiabetic treatment in type 2 diabetes.

Ampudia-Blasco FJ, García-Soidán FJ, Rubio Sánchez M, Phan TM. Ampudia-Blasco FJ, et al. Endocrinol Diabetes Nutr. 2017 Mar;64(3):128-137. doi: 10.1016/j.endinu.2016.11.007. Epub 2017 Feb 9. Endocrinol Diabetes Nutr. 2017. PMID: 28440751 English, Spanish.

10

Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.

Rossetti P, Quirós C, Moscardó V, Comas A, Giménez M, Ampudia-Blasco FJ, León F, Montaser E, Conget I, Bondia J, Vehí J. Rossetti P, et al. Diabetes Technol Ther. 2017 Jun;19(6):355-362. doi: 10.1089/dia.2016.0443. Epub 2017 May 1. Diabetes Technol Ther. 2017. PMID: 28459603 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page